A panel of experts discuss the value of clinical pathways in MM disease management. Ryan Haumschild, PharmD, MS, MBA: Let’s talk about clinical pathways. We’ve seen pathways continue to emerge. One ...

A research team from Rice University led by Aryeh Warmflash has made strides in understanding the processes that guide human embryonic development. The group's findings were published in the journal ...

Treating complex, multifactorial diseases is one of the top challenges in clinical practice today. Like many other chronic diseases that burden the healthcare system, multiple signaling pathways are ...

The interconnectedness of the brain, body and lifestyle factors and how they collectively influence mental health has been demonstrated by new research. Researchers from the University of Melbourne, ...

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated multiple routes that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might take to develop high-level ...

Cross-talk between brain cells and peripheral immune cells can modulate the progression of multiple sclerosis (MS), Mount Sinai researchers have discovered. Their findings reveal a previously unknown ...

Many cancers harbor pro-proliferative mutations of the mitogen-activated protein kinase (MAPK) pathway. In BRAF-driven melanoma cells treated with BRAF inhibitors, subpopulations of cells escape ...

NEW DELHI, May 2 (Reuters) - India, backed by China, is trying to build a consensus within the G20 group to let countries choose a roadmap to cut carbon emissions instead of setting a deadline to end ...

Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS). This disease causes the immune system to mistakenly attack the protective ...